⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OSTX News
OS Therapies Incorporated
OS Therapies Announces the Publication of Four Articles on OST-HER2 and Osteosarcoma in Drug Discovery World Ready to Announce with Confidence?
newsfilecorp.com
OSTX
OS Therapies to Attend Upcoming Medical, Financial and Industry Conferences Ready to Announce with Confidence?
newsfilecorp.com
OSTX
OS Therapies Reports First Quarter 2026 Financials and Provides Business Update Ready to Announce with Confidence?
newsfilecorp.com
OSTX
OS Therapies to Announce First Quarter 2026 Financials on Monday, May 18, 2026 Ready to Announce with Confidence?
newsfilecorp.com
OSTX
OS Therapies Appoints Industry Leader Dr. Craig Eagle as Chief Medical Advisor Ready to Announce with Confidence?
newsfilecorp.com
OSTX
Stonegate Capital Partners Updates Coverage on MarketWise (MKTW) 1Q26 Ready to Announce with Confidence?
newsfilecorp.com
MKTW
OSTX
VMD
Stonegate Capital Partners Updates Coverage on OS Therapies Inc. (OSTX) Ready to Announce with Confidence?
newsfilecorp.com
OSTX
Form 8-K
sec.gov
OSTX
OS Therapies Announces EMA Initiates Rolling Review of Conditional Marketing Authorization Application for OST-HER2 in the Prevention or Delay of Recurrence in Fully Resected Pulmonary Metastatic Osteosarcoma Ready to Announce with Confidence?
newsfilecorp.com
OSTX
OS Therapies Schedules OST-HER2 Pharmacodynamic Response Biomarker Conference Call on April 30, 2026 at 8:30am ET Ready to Announce with Confidence?
newsfilecorp.com
OSTX